Daily Archives: January 14, 2019

DoubleVerify Acquires Leiki – Leading Contextual Intelligence Platform

Acquisition Fortifies DV Brand Safety Solutions Globally

NEW YORK, Jan. 14, 2019 (GLOBE NEWSWIRE) — DoubleVerify, the leading independent provider of marketing measurement software and analytics, today announced that it has acquired Leiki, Ltd., a leading contextual intelligence and content classification platform headquartered in Helsinki, Finland, and with operations across Europe. The transaction was completed as an all cash, all stock offer on December 27, 2018.

The Leiki acquisition further strengthens DV’s core global brand reputation capabilities, ensuring that brands advertising on the Internet are matched with appropriate and relevant content.  Leiki’s semantic AI software engine provides high-definition analysis of any piece of text (e.g. complex news articles) or contextual video data. DoubleVerify uses content analysis data to protect brand reputation throughout the media transaction (pre- and post-bid) and to enable proactive contextual targeting of content aligned with a brand’s equity or target audience profile.

The acquisition also brings a tenured team with specialized ontological expertise and deep relationships with brands and premium publishers internationally. Moreover, Leiki experts classify content in-language worldwide – helping DV address the brand reputation needs of its global customer base.

Commenting on the acquisition, Wayne Gattinella, DoubleVerify CEO, said:

“Leiki’s data-driven technology platform and advanced content classification expertise dovetail perfectly with DV’s global brand reputation offering – a core competency since our company’s inception over a decade ago. We are delighted to welcome the Leiki team – a uniquely talented group that is expert in language ontology and content analysis.”

Leiki CEO and Founder, Dr. Petrus Pennanen added:

“The entire Leiki team is thrilled to join forces with DoubleVerify – a rapidly expanding, global organization with a best-in-class brand reputation solution. We are going to market with even stronger capabilities through close integration of Leiki’s semantic technology and expertise with DV’s industry-wide platform.”

About DoubleVerify
DoubleVerify is the leading independent provider of marketing measurement software, data and analytics that authenticates the quality and effectiveness of digital media for the world’s largest brands and media platforms. DV provides media transparency and accountability to deliver the highest level of impression quality for maximum advertising performance. Since 2008, DV has helped hundreds of Fortune 500 companies gain the most from their media spend by delivering best in class solutions across the digital ecosystem, helping to build a better industry. Learn more at doubleverify.com.

About Leiki
Founded in 2000, Leiki provides a leading, independent semantic AI platform that offers a variety of software as a service (SaaS) solutions for brands and publishers. At its technological core, Leiki has a proprietary natural language analysis ontology with over 200 thousand topics, powering text and audience interest analysis, content discovery, and user interest profiling and segmentation. Leiki’s technology has numerous applications within the online advertising sector, including concept recognition, content classification and recommendation, and semantic search – in addition to intelligent user profiling, based on interest and intent. Leiki is headquartered in Helsinki, Finland with operations across North America and Europe.

PR Contact:
Chris Harihar of Crenshaw Communications, on behalf of DoubleVerify

PSAV® and The Freeman Company Announce Purchase Agreement for PSAV to Acquire Encore Event Technologies

SCHILLER PARK, IL, and DALLAS,TX, Jan. 14, 2019 (GLOBE NEWSWIRE) — PSAV, a global leader in event experiences, and The Freeman Company, jointly announced today that the companies have entered into a purchase agreement for PSAV to acquire Encore Event Technologies, a global provider of event technology, staging and production services.  The combination of PSAV and Encore will join two companies with deep expertise and a shared commitment to be an invaluable global partner for the meeting industry.  This transaction reinforces PSAV’s mission of Connecting and Inspiring People by expanding the breadth of its capabilities throughout North America and Asia Pacific.  The transaction is expected to be finalized later this year. Terms of the transaction will not be disclosed.

Encore has a long and distinguished history dedicated to helping create high-impact meetings and live events for the hospitality industry. Encore operates as both an in-house partner to some of the world’s leading resorts, hotels and casinos, as well as a creative production company for clients around the world.

“Encore is an ideal partner for the PSAV family of companies given its shared commitment to meeting and event planners, and strong alignment with our purpose and mission,” said Mike McIlwain, CEO of PSAV.  I am excited about what this means for PSAV, and more importantly our customers, as we continue to focus on more ways to create amazing event experiences wherever an event is held.”

“We’re extremely proud of the success everyone at Encore – including our FAV Canada operations – has created in building one of the world’s leading in-house hospitality, event technology and production service businesses,” said Joe Popolo, CEO of The Freeman Company. “At Freeman, we continue our mission to provide powerful brand experiences, which include our audio visual solutions, for association and corporate customers around the world.”

“It has been an honor to lead and develop Encore and to witness its growth,” said Ken Sanders, chief development officer, The Freeman Company. “I want to thank everyone at Encore for applying their work, skills, dedication and creativity to build this world-class company, and I look forward to watching their continued prosperity as part of PSAV.”

Peter Wallace and David Kestnbaum of Blackstone’s Private Equity team commented, “We are excited about the combination of our portfolio company, PSAV, with Encore.  Blackstone sees continued growth opportunities in live events, and we are pleased that Encore will bring additional capabilities to support event planners and our venue partners.”

Bill Stein of Blackstone’s Real Estate team added, “The combination of PSAV and Encore will further enhance our strong capabilities to serve meeting event planners and our venue partners across a diverse suite of services as part of our mission of creating a world-class, diversified global live events platform.”

Simpson Thacher & Bartlett LLP is serving as legal counsel to PSAV.

JP Morgan is serving as financial advisor to Freeman and Encore, and Baker McKenzie is serving as legal counsel to Freeman and Encore. 

About PSAV®

PSAV is a global leader in event experiences, providing creative, production, advanced technology and staging services to help meeting professionals deliver more dynamic and impactful experiences at their meetings, trade shows and events. The team consists of more than 9,000 professionals across 1,500 on-site venue locations and 49 branch offices within the United States, Canada, Mexico, Europe, the Caribbean, and the Middle East. It is the trusted partner and on-site provider of choice at leading venues worldwide. PSAV was recently named to the Forbes 2018 America’s Best Employer list. The company is headquartered in Schiller Park, Ill.  www.psav.com. 

About The Freeman Company

The Freeman Company helps create meaningful connections for all types of global audiences. The family-owned company is comprised of leading brand experience company, Freeman; audio-visual and production company, Encore Event Technologies; and Alford Media, a premier event technology specialist known for the expertise and precision on large-scale shows. With more than 90 locations globally and 7,000+ employees who are dedicated to delivering the best experiences and business outcomes possible for their clients — from strategy and design to implementation and results. For more information, visit http://www.freeman.com/  

About Encore Event Technologies

Encore is a leading global provider of audiovisual, event technology, staging and production services.  Encore serves as the in-house provider at more than 460 hotels, casinos, conference centers and resorts in North America and Asia Pacific.  Encore Productions, the production division of Encore Event Technologies, is a full-service creative production company helping clients tell their stories around the world.  For more information, visit www.encore-us.comwww.encore-anzpac.com and www.freemanav-ca.com.


Bob Niersbach

Stephen Phillips
(214) 445-1205

TRIO Enrolls First Patient Into PHASE III NATALEE Clinical Trial

Timely Enrollment Signifies Milestone in TRIO

EDMONTON, Alberta, Jan. 14, 2019 (GLOBE NEWSWIRE) — Translational Research In Oncology (TRIO), in collaboration with Novartis and under the direction of Dennis Slamon, MD, PhD, TRIO Chairman/Executive Director and Director of Clinical Translational Research at the University of California, Los Angeles Jonsson Comprehensive Cancer Center, announces enrollment of the first patient into its newest clinical trial, NATALEE (New Adjuvant TriAl with LEE).

NATALEE is a randomized, phase III clinical trial testing the efficacy and safety of ribociclib and endocrine therapy in the adjuvant treatment of Hormone Receptor-positive, HER2-negative early breast cancer. The trial will test a daily 400 mg dose of ribociclib on a three week on, one week off cycle with endocrine therapy, against endocrine therapy alone. The combination of ribociclib with endocrine therapy has shown to be effective in previous advanced breast cancer clinical trials, leading to the approval of ribociclib in this setting. The primary endpoint of NATALEE is invasive disease-free survival (iDFS) using STEEP (Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials) criteria.

“The speed with which we’ve enrolled our first patient reflects the energy we put into every one of our clinical trials. It also reflects the strength of our relationship with our investigator network and in particular, the efficiency of the TRIO-US team who enrolled our first patient,” says Launa J Aspeslet, PhD, CEO of TRIO. “We deeply appreciate the sacrifices every breast cancer patient makes to help us achieve our goal of a world where all patients with breast cancer can be cured.”

This patient marks the first of more than 4,000 patients expected to enroll in NATALEE, TRIO’s largest clinical trial to date. NATALEE is projected to include hundreds of international sites within TRIO’s network and Novartis recommended sites. NATALEE will be conducted over the next seven years. TRIO has extensive experience with breast cancer clinical trials, most notably in the development of trastuzumab for HER2-positive breast cancer and more recently with CDK 4/6 inhibitors.

“NATALEE is an exciting culmination of TRIO’s efforts in translating our past preclinical results into clinical trials, especially with regards to breast cancer and the role of CDK 4/6 inhibition in that disease,” says Dr. Slamon. “Our collaboration with Novartis and our global network of investigator sites will be a great  collective effort over the next few years.”

For more information on NATALEE, visit https://clinicaltrials.gov/ct2/show/NCT03701334.

Ribociclib was developed by the Novartis Institutes for BioMedical Research (NIBR) under a research collaboration with Astex Pharmaceuticals.

About TRIO:

TRIO advances translational cancer research by introducing innovative and novel targeted therapeutic concepts into the clinical trial setting. With international offices in Edmonton (Canada), Paris (France), Montevideo (Uruguay), TRIO’s global reach is expansive. Our goal as a clinical research organization is to find the shortest path to saving lives. Additional information on TRIO can be found by visiting https://www.trioncology.org. Interested parties may also follow TRIO on Twitter (twitter.com/TRIOncology).

For more information, contact:

Launa Aspeslet, PhD, RAC
Email: launa.aspeslet@trioncology.org
Phone: 780-702-2260

Matthieu Rupin, MSc
Director Strategy and Clinical Collaborations, TRIO
Email: matthieu.rupin@trioncology.org
Phone: (+33) 1 58 10 08 89

Alberta set to welcome next generation of AI experts

EDMONTON, Alberta, Jan. 14, 2019 (GLOBE NEWSWIRE) — The Alberta Machine Intelligence Institute (Amii) has launched applications for the 11thannual Deep Learning and Reinforcement Learning Summer School, happening July 24 – August 2, 2019 at the University of Alberta in Edmonton, Canada. Hosted in partnership with CIFAR, the Summer School brings together graduate students, post-doctoral fellows and industry professionals to explore the latest AI techniques, build research networks and open collaborative opportunities.

“We’re excited to be hosting this year’s Summer School here in Edmonton and to welcome the future experts of our industry from across the world,” says John Shillington, CEO of Amii. “It’s often a surprise for people to learn that Edmonton is a hub for AI research and home to some of the brightest minds in the field, so we’re thrilled to be able to show the world all the things this unique research community has to offer.”

Over the 10-day intensive program, participants will learn directly from world-renowned AI researchers including Amii’s own Richard Sutton and Martha White and other global leaders like Yoshua Bengio of the University of Montreal. Programming also includes an AI Career Fair and social events, meant to ignite conversations around the major questions across multiple sectors.

“The Summer School has become a beacon for top AI students and experts from around the world,” says Elissa Strome, Executive Director of the Pan-Canadian AI Strategy at CIFAR. “We’re excited to showcase what makes Canada a global leader in the field of AI.”

Amii and CIFAR are also pleased to present a new event in coordination with the 2019 Summer School: the Summer Institute on AI Societal Impacts, Governance, and Ethics from July 22 – 23. The Summer Institute will host scholars from a variety of disciplines to examine the societal, governmental, and ethical implications of AI.

The Deep Learning and Reinforcement Learning Summer School takes place July 24 – August 2, 2019 at the University of Alberta in Edmonton, Canada, and is hosted by Amii and CIFAR, with participation and support from Canada’s other AI hubs: Toronto’s Vector Institute and Mila in Montreal.

Visit www.dlrlsummerschool.ca to apply and for more information. Follow the conversation through social media channels using the hashtag #DLRLSS2019.

About Amii: One of three centres of excellence in Canada’s national AI Strategy, the Alberta Machine Intelligence Institute (Amii) performs advanced research in the fields of machine learning and artificial intelligence and guides businesses as they grow their AI capabilities. Amii supports world-leading research and training at the University of Alberta and acts as a catalyst for transformative growth for Alberta and Alberta-based businesses through machine intelligence.
Learn more at www.amii.ca | Amii Fact Sheet

About CIFAR: CIFAR brings together outstanding researchers from across disciplines and borders to address important challenges facing the world. CIFAR supports leading edge research with the potential for global impact. In 2017, CIFAR was chosen by the Canadian government to lead the $125 million Pan-Canadian Artificial Intelligence Strategy.

Primary Media Contact: Spencer Murray, Director of Communications & Public Relations, Amii
t: 587.415.6100 | c: 780.991.7136 | e: spencer.murray@amii.ca

Secondary Media Contact: Brittany Ayotte, Communications Associate, Amii
t: 587.415.6100 | c: 780.709-8025 | e: brittany.ayotte@amii.ca

A PDF accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/7b087a02-e347-47d6-9f76-0c6acac23cfa

CP Kelco Receives Non-GMO Project Verification for 19 GENU® Pectin Products

ATLANTA, Jan. 14, 2019 (GLOBE NEWSWIRE) — CP Kelco, a leading global producer of specialty hydrocolloid solutions, announced today that the following 19 GENU® Pectin products are Non-GMO Project (NGP) verified:

  • GENU® BETA Pectin
  • GENU® Pectin type B rapid set
  • GENU® Pectin type D slow set
  • GENU® Pectin type DD extra slow set
  • GENU® Pectin type LM-12 CG
  • GENU® Pectin type LM-12-CG-Z
  • GENU® Pectin type LM-18 CG
  • GENU® Pectin type LM-22 CG
  • GENU® Pectin type LM-101 AS
  • GENU® Pectin type LM-102 AS
  • GENU® Pectin type LM-104 AS
  • GENU® Pectin type LM-105 AS
  • GENU® Pectin type JMJ
  • GENU® Pectin type YM-100-H
  • GENU® Pectin type YM-150-H
  • GENU® Pectin type YM-100-L
  • GENU® Pectin VIS-Z
  • GENU® Pectin type YM-115-L
  • GENU® Pectin type YM-115-H

NGP is a nonprofit organization dedicated to building and protecting a non-GMO food supply in North America.

Pectin, which is extracted from citrus peel, provides unique gelling, thickening and stabilizing properties in various food and beverage applications, including fruit juices, acidified protein drinks, jams, jellies, bakery mixes and fillings, dairy desserts and beverages, soups and sauces and it serves as a gelatin replacement in desserts and gels, amongst others.

“With our history of technical expertise, ongoing research and problem-solving with customers, we serve as an extension of a food manufacturer’s R&D team and understand the challenges of keeping up with food industry trends,” said Jérôme Béra, Senior Vice President of Global Marketing at CP Kelco. “We have seen increasing consumer interest in NGP-verified consumer products in North America and we strive to help our customers by achieving the verification for some of our key products. Shortening the NGP verification process makes it easier for our customers to introduce new products on shelves.”

For the most up-to-date list of CP Kelco NGP-verified products, visit the Non-GMO Project website. To learn more about these products and how to develop or improve formulations, send an email to solutions@cpkelco.com or visit http://www.cpkelco.com/.

About CP Kelco

Headquartered in Atlanta, Georgia, USA, and part of J.M. Huber Corporation, CP Kelco is a leading producer of specialty hydrocolloids with offices and facilities across the globe. Featuring an extensive range of hydrocolloid solutions and serving over 100 countries, CP Kelco leverages its capabilities to bring concepts and ideas to real-world products in a broad range of applications. The company’s specialty ingredients touch a wide variety of consumer and household products and industrial applications, tailored to meet the needs of regional consumers. Key product lines are Gellan Gum, Pectin, Xanthan Gum, Cellulose Gum, Carrageenan, Diutan Gum and Microparticulated Whey Protein Concentrate, as well as other unique biopolymers. Visit http://www.cpkelco.com/ for more information.

Michele Cacdac-Jones
Office: +1 678 247 7149
Mobile: +1 770 743 0564